We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is a Dopamine Agonist?

Tricia Christensen
By
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

A dopamine agonist is an interesting medication that is most useful in early treatment of Parkinson’s disease and in conditions like restless legs syndrome (RLS). Its mechanism of action is to work on dopamine receptors so that they are stimulated. This is different than adding dopamine to the body, which would stimulate the receptors, and it’s also distinct from preventing the body from taking up (reuptake) free dopamine so there is more in use. Instead, it’s something like a substitute for dopamine that can fool dopamine receptors into working, even when the body lacks a good supply of this neurotransmitter.

One of the reasons why dopamine agonist drugs can be of great use in treating diseases like Parkinson’s is due to the diminishing presence of dopamine in this condition. A steadily decreasing supply of this neurotransmitter translates to many of the developing symptoms of the disease. While in late stages, giving medications like straight dopamine or L-dopa might be part of treatment, in early stages, a dopamine agonist may be of most use in preventing symptoms from progressing. In conditions like RLS, a dopamine agonist may not only slow disease progression, but could result in complete cessation of symptoms, while the drug remains in use.

There are a number of dopamine agonist medications that are in use for different conditions. For RLS, drugs like pramiprexole (Mirapex®) and ropinirole (Requip®) are common choices. With Parkinson’s disease cabergoline or bromocriptine might be the best choices. Other medications with dopamine agonist properties exist and might be chosen instead, depending on a patient’s individual circumstances. Medications for RLS may be useful in calming restless sensations and for Parkinson’s may be able to reduce involuntary movements.

Such drugs do have side effects including possibility of increasing involuntary movements, or causing severe mood disturbance, especially in people with mood disorders. Alternately, some people taking these medications may feel overly happy, leading to poor judgment about spending or consuming alcohol. Other side effects reported include tiredness, dizziness, light-headedness, faint feelings, trouble sleeping, changes in weight, hallucinations, and low blood pressure. Any incidence of side effects varies by person, dose adjustment sometimes rids the person of side effects, and switching to a different dopamine agonist may alleviate issues.

One of the more profound reactions to these medications is change in behavior that could include development of compulsive or addictive behaviors like gambling, drug use or sexual addiction. In the first decade of the 2000s, a number of lawsuits have arisen against drug companies for not warning people of these serious effects, which were certainly known earlier. While these drugs may be viewed as important, all people contemplating taking a dopamine agonist should make themselves fully aware of potential side effects. This allows folks to report any side effects early and get medical advice on other treatments that might be more appropriate.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Tricia Christensen
By Tricia Christensen , Writer
With a Literature degree from Sonoma State University and years of experience as a The Health Board contributor, Tricia Christensen is based in Northern California and brings a wealth of knowledge and passion to her writing. Her wide-ranging interests include reading, writing, medicine, art, film, history, politics, ethics, and religion, all of which she incorporates into her informative articles. Tricia is currently working on her first novel.

Discussion Comments

By hyrax53 — On Feb 23, 2011

I am skeptical of a lot of these types of medications. While I think they help a lot of people, I would personally not want to take any medication which affected my brain chemistry unless there was no other option.

By watson42 — On Feb 22, 2011

When someone is considering any drug that affects the way the brain works, such as with dopamine here, it is important that people close to him or her, either family or friends, know and are able to help monitor that person, especially when treatment is beginning. In some cases these side effects can occur extremely quickly and dramatically, and a support system can be necessary to avoid risky behavior from someone being excessively happy or sad.

Tricia Christensen

Tricia Christensen

Writer

With a Literature degree from Sonoma State University and years of experience as a The Health Board contributor, Tricia...
Learn more
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.